Strumento inattivo

Altre lingue Veloxis Pharmaceuticals A/S CBOE EUROPE EQUITIES

Azioni

0IVI

DK0060048148

Prezzo di chiusura CBOE EUROPE EQUITIES Altri mercati azionari
- ^DKK	-

30/05	Veloxis Pharmaceuticals A/S sceglie di presentare al Congresso Americano dei Trapianti 2024 a Philadelphia	CI
2022	Veloxis Pharmaceuticals annuncia il dosaggio del primo paziente da parte del partner Xenikos nello studio globale di fase 3 che valuta T-Guard(R) nei pazienti con malattia acuta del trapianto-vitello refrattaria agli steroidi (SR-aGVHD).	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Veloxis Pharmaceuticals A/S Selects to Present At the 2024 American Transplant Congress in Philadelphia	30/05
Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)	28/06/22
Scandion Oncology A/S : appoints Johnny Stilou as new CFO	02/06/21
Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.	26/04/21
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020	17/02/20
Veloxis Pharmaceuticals A/S Announces Board Appointments	17/02/20
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index	07/02/20
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index	30/01/20
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index	30/01/20
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S	29/01/20
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting	27/01/20
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S	27/01/20
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications	27/01/20
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting	24/01/20
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen	24/01/20
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S	24/01/20
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications	24/01/20
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer	23/01/20
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer	20/01/20
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer	17/01/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Veloxis Pharmaceuticals A/S CBOE EUROPE EQUITIES

Azioni

0IVI

DK0060048148

Altre lingue

Filtri